<DOC>
	<DOCNO>NCT02004262</DOCNO>
	<brief_summary>Test safety , immune response efficacy GVAX pancreas vaccine ( cyclophosphamide ) CRS-207 compare chemotherapy CRS-207 alone adults previously treat metastatic pancreatic adenocarcinoma</brief_summary>
	<brief_title>Safety Efficacy Combination Listeria/GVAX Pancreas Vaccine Pancreatic Cancer Setting</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Erlotinib Hydrochloride</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Have histologically proven malignant adenocarcinoma pancreas ; measurable disease require , mixed histology allow ; subject must metastatic disease 2nd line , 3rd line great At least 18 year age ECOG 0 1 Anticipated life expectancy &gt; 12 week For woman men childbearing potential , medically acceptable method highly effective contraception ( oral hormonal contraceptive , condom plus spermicide , hormone implant ) must use throughout study period 28 day final vaccine administration . ( A barrier method contraception must employ subject [ male female ] , regardless method . ) Have adequate organ function define specified laboratory value Allergy penicillin &amp; sulfa suspect hypersensitivity GMCSF , dimethyl sulfoxide , fetal bovine serum , trypsin , yeast , glycerol component therapy option Known history evidence brain metastasis , immunodeficiency disease immunocompromised state history autoimmune disease require systemic steroid immunosuppressive treatment Have evidence hepatic cirrhosis clinical radiographic ascites Have prosthetic heart valve , major implant device place last 12 month history infection implant/device easily remove Rapidly progress disease Clinically significant and/or malignant pleural effusion Received prior GVAX pancreas vaccine CRS207 Major surgery significant traumatic injury ( unhealed surgical wound ) occur within 28 day prior receive study drug , plan surgery require general anesthesia Infection HIV hepatitis B C screen Valvular heart disease require antibiotic prophylaxis prevention endocarditis Be pregnant breastfeed Unable avoid close contact another individual know high risk listeriosis ( e.g. , newborn infant , pregnant woman , HIVpositive individual ) course CRS207 treatment completion antibiotic regimen Conditions , include alcohol drug dependence , intercurrent illness , lack sufficient peripheral venous access , would affect patient 's ability comply study visit procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>cancer</keyword>
	<keyword>cancer vaccine</keyword>
	<keyword>Listeria monocytogenes</keyword>
	<keyword>Listeria-based vaccine</keyword>
	<keyword>GVAX</keyword>
	<keyword>cyclophosphamide</keyword>
	<keyword>Cytoxan</keyword>
	<keyword>immunotherapy</keyword>
	<keyword>mesothelin</keyword>
</DOC>